Low-coverage whole-genome sequencing of cerebrospinal-fluid-derived  cell-free DNA in brain tumor patients - ScienceDirect

Low-coverage whole-genome sequencing of cerebrospinal-fluid-derived cell-free DNA in brain tumor patients - ScienceDirect

4.6
(644)
Write Review
More
$ 22.50
Add to Cart
In stock
Description

Detection of cell‐free DNA fragmentation and copy number alterations in cerebrospinal fluid from glioma patients

Serial assessment of measurable residual disease in medulloblastoma liquid biopsies - ScienceDirect

Cerebrospinal fluid: A unique source of circulating tumor DNA with broad clinical applications - ScienceDirect

Circulating tumour DNA from the cerebrospinal fluid allows the characterisation and monitoring of medulloblastoma

Circulating cell-free DNA for cancer early detection - ScienceDirect

Serial assessment of measurable residual disease in medulloblastoma liquid biopsies - ScienceDirect

Sequencing of cerebrospinal fluid cell-free DNA facilitated early differential diagnosis of intramedullary spinal cord tumors

Dynamic monitoring of cerebrospinal fluid circulating tumor DNA to identify unique genetic profiles of brain metastatic tumors and better predict intracranial tumor responses in non-small cell lung cancer patients with brain metastases

Sequencing of cerebrospinal fluid cell-free DNA facilitated early differential diagnosis of intramedullary spinal cord tumors

Clinical Experience of Cerebrospinal Fluid–Based Liquid Biopsy Demonstrates Superiority of Cell-Free DNA over Cell Pellet Genomic DNA for Molecular Profiling - ScienceDirect

Cancers, Free Full-Text